NTAGI meeting will be held today to discuss giving Corbevax as a booster dose IG News

Corbevax Covid-19 Vaccine of Biological E. (Photo: ANI)

New Delhi: Sources said allowing Biologics E’s Corbevax as a booster for those fully immunized against Covid-19 with Covishield or Covaxin may be considered by the NTAGI, which is due to meet on Tuesday.

The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precautionary dose for people aged 18 years and above. India’s first indigenously developed RBD protein subunit vaccine, Corbevax, is currently being used to vaccinate children in the age group of 12 to 14 years.

A source told PTI, “The National Technical Advisory Group on Immunization (NTAGI) will discuss allowing Corbevax, which has been approved by DCGI as a booster for those fully vaccinated with Kovashield or Covaxin. “

The government advisory panel is also expected to review trial data for the country’s first quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer developed by the Serum Institute of India.

Sources had said that a separate HPV working group at NTAGI had on June 8 examined clinical trial data of the vaccine and its utility for inclusion in the national immunization programme.

A meeting to be chaired by the Union Health Secretary may also confirm the recommendation of the Standing Technical Sub-Committee (STSC) of NTAGI to reduce the gap between the second dose and the precautionary dose of Kovid vaccines from nine to six months. . ,

Also read: India Record 11,793 new covid cases, 30% less than the previous day